113 related articles for article (PubMed ID: 1866710)
1. Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit.
Bevilacqua C; Finesso M; Prosdocimi M
Thromb Res; 1991 May; 62(4):263-73. PubMed ID: 1866710
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals.
Sturgeon SA; Jones C; Angus JA; Wright CE
J Pharmacol Toxicol Methods; 2006; 53(1):20-9. PubMed ID: 16087355
[TBL] [Abstract][Full Text] [Related]
3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
4. The effect of thrombin inhibition in a rat arterial thrombosis model.
Broersma RJ; Kutcher LW; Heminger EF
Thromb Res; 1991 Nov; 64(4):405-12. PubMed ID: 1788827
[TBL] [Abstract][Full Text] [Related]
5. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
Kaiser B; Fareed J
Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
[TBL] [Abstract][Full Text] [Related]
6. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
Rote WE; Nedelman MA; Mu DX; Manley PJ; Weisman H; Cunningham MR; Lucchesi BR
Stroke; 1994 Jun; 25(6):1223-32; discussion 1233. PubMed ID: 8202985
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
[TBL] [Abstract][Full Text] [Related]
8. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents.
Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464
[TBL] [Abstract][Full Text] [Related]
9. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
10. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane antagonism in experimental canine carotid artery thrombosis.
Rote WE; Mu DX; Lucchesi BR
Stroke; 1993 Jun; 24(6):820-7; discussion 827-8. PubMed ID: 8506554
[TBL] [Abstract][Full Text] [Related]
12. Experimental carotid thrombosis in the guinea pig.
Roux S; Carteaux JP; Hess P; Falivene L; Clozel JP
Thromb Haemost; 1994 Feb; 71(2):252-6. PubMed ID: 8191408
[TBL] [Abstract][Full Text] [Related]
13. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor.
Pakala R; Liang CT; Benedict CR
Thromb Res; 2000 Oct; 100(1):89-96. PubMed ID: 11053621
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model.
Thiagarajan P; Benedict CR
Circulation; 1997 Oct; 96(7):2339-47. PubMed ID: 9337209
[TBL] [Abstract][Full Text] [Related]
16. Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis.
Carteaux JP; Gast A; Tschopp TB; Roux S
Circulation; 1995 Mar; 91(5):1568-74. PubMed ID: 7867200
[TBL] [Abstract][Full Text] [Related]
17. Prevention of experimental carotid artery thrombosis by applaggin.
Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
[TBL] [Abstract][Full Text] [Related]
18. An animal model for the study of arterial thrombosis.
Ubatuba FB
Braz J Med Biol Res; 1989; 22(8):993-1000. PubMed ID: 2517408
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis prevention.
Chan AK; Rak J; Berry L; Liao P; Vlasin M; Weitz J; Klement P
Circulation; 2002 Jul; 106(2):261-5. PubMed ID: 12105168
[TBL] [Abstract][Full Text] [Related]
20. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase.
Leach JK; O'Rear EA; Patterson E; Miao Y; Johnson AE
Thromb Haemost; 2003 Jul; 90(1):64-70. PubMed ID: 12876627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
